About Us

InterceptAge is a pioneering biotechnology company based in San Diego, California, dedicated to advancing regenerative and rejuvenation therapies. Founded in 2025 (former BioIntercept), we are at the forefront of addressing the challenges of traditional stem cell therapies, such as immune rejection, tumorigenicity, and instability to promote tissue repair, combat age-related degeneration, and enhance overall wellness. We are committed to transforming healthcare by delivering impactful solutions that enable true regeneration and unprecedented rejuvenation. With provisional patents filed and a focus on scalable commercialization, our platform outperforms industry standards, providing superior potency, long-term bioactivity, and several non-invasive administration routes.

Our Mission

To overcome the barriers in regenerative and anti-aging therapies by developing safe, effective, and accessible treatments that improve quality of life for an aging global population. We aim to capture first-to-market advantages in high-growth segments like degenerative conditions, systemic rejuvenation and cosmetics.

Our Technology

Our stem cell-based products are derived from diverse sources, featuring a comprehensive blend of bioactive factors that significantly upregulate key cytokines for angiogenesis, collagen production, and immune modulation—while eliminating inflammatory risks.

Our Team

Our success is driven by a world-class team of experts with decades of experience in stem cell research, bioprocessing, and regulatory compliance.

Join Us in Shaping the Future

InterceptAge is poised to lead the regenerative medicine revolution. We invite partners, investors, and collaborators to join us in bringing these transformative therapies to market. For more information, contact us at